Biogen Inc.
Overview
Biogen Inc. is a global biotechnology company specializing in the discovery, development, and delivery of therapies for neurological and neurodegenerative diseases. Biogen is committed to advancing pioneering science to address some of the most challenging diseases affecting humanity.
Therapeutic areas
FDA compliance signals
6 FDA enforcement records linked to this company.
- 4832017-04-06
Late submission of 15-day report
- 4832017-04-06
Late submission of annual safety reports
- 4832015-06-26
Procedures for non-sterile drug products
- 4832015-06-26
Procedures not in writing, fully followed
- 4832014-07-03
Late submission of 15-day report
- 4832014-07-03
Non-applicant reports directly to FDA
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.